Cite
Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease-characterization and treatment compliance assessment.
MLA
Cardoso, Ana Verónica, et al. “Obstructive Sleep Apnoea in Patients with Fibrotic Diffuse Parenchymal Lung Disease-Characterization and Treatment Compliance Assessment.” Canadian Journal of Respiratory Therapy : CJRT = Revue Canadienne de La Therapie Respiratoire : RCTR, vol. 54, no. 2, Summer 2018, pp. 35–40. EBSCOhost, https://doi.org/10.29390/cjrt-2018-005.
APA
Cardoso, A. V., Pereira, N., Neves, I., Santos, V., Jesus, J. M., Melo, N., Mota, P. C., Morais, A., & Drummond, M. (2018). Obstructive sleep apnoea in patients with fibrotic diffuse parenchymal lung disease-characterization and treatment compliance assessment. Canadian Journal of Respiratory Therapy : CJRT = Revue Canadienne de La Therapie Respiratoire : RCTR, 54(2), 35–40. https://doi.org/10.29390/cjrt-2018-005
Chicago
Cardoso, Ana Verónica, Nuno Pereira, Inês Neves, Vanessa Santos, José Miguel Jesus, Natália Melo, Patrícia Caetano Mota, António Morais, and Marta Drummond. 2018. “Obstructive Sleep Apnoea in Patients with Fibrotic Diffuse Parenchymal Lung Disease-Characterization and Treatment Compliance Assessment.” Canadian Journal of Respiratory Therapy : CJRT = Revue Canadienne de La Therapie Respiratoire : RCTR 54 (2): 35–40. doi:10.29390/cjrt-2018-005.